These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24658070)

  • 1. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
    PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Liao YH; Zhao MH
    J Clin Immunol; 2013 Jan; 33(1):172-8. PubMed ID: 22941511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement in ANCA-associated glomerulonephritis.
    Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
    O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
    Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis.
    Xing GQ; Chen M; Liu G; Zheng X; E J; Zhao MH
    J Clin Immunol; 2010 Jan; 30(1):144-56. PubMed ID: 19898926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort.
    Shen CR; Jia XY; Cui Z; Yu XJ; Zhao MH
    Front Immunol; 2020; 11():2035. PubMed ID: 33013861
    [No Abstract]   [Full Text] [Related]  

  • 7. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
    Zhao M; Ding J; Liu Y; Zou W; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.
    Tang A; Zhao X; Tao T; Xie D; Xu B; Huang Y; Li M
    Front Immunol; 2023; 14():1229806. PubMed ID: 37781380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular C1q deposition and serum anti-C1q antibodies in anti-glomerular basement membrane disease.
    Hu SY; Jia XY; Yang XW; Yu F; Cui Z; Zhao MH
    BMC Immunol; 2013 Sep; 14():42. PubMed ID: 24053688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Activation Is Associated With Crescents in IgA Nephropathy.
    Wang Z; Xie X; Li J; Zhang X; He J; Wang M; Lv J; Zhang H
    Front Immunol; 2021; 12():676919. PubMed ID: 34594322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
    Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
    Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Activation in Kidneys of Patients With COVID-19.
    Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2020; 11():594849. PubMed ID: 33584662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
    Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J; Miller K; Michael AF
    Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis.
    Xing GQ; Chen M; Liu G; Heeringa P; Zhang JJ; Zheng X; E J; Kallenberg CG; Zhao MH
    J Clin Immunol; 2009 May; 29(3):282-91. PubMed ID: 19067130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
    Sund S; Hovig T; Reisaeter AV; Scott H; Bentdal Ø; Mollnes TE
    Transplantation; 2003 Apr; 75(8):1204-13. PubMed ID: 12717204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease.
    Qu Z; Cui Z; Liu G; Zhao MH
    BMC Immunol; 2013 Apr; 14():19. PubMed ID: 23586976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
    Silva FG; Hoyer JR; Pirani CL
    Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
    Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
    BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.